Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chamo Bürger Kamillenpuder is a topical herbal powder developed by Johannes Bürger YS Lab for the treatment of mild skin and mucous membrane inflammations. The formulation contains pharmaceutical-quality chamomile flower fluid extract and chamomile oil, which are rich in active constituents such as apigenin-7-glucoside, chamazulene, and alpha-bisabolol. These components provide anti-inflammatory, soothing, and antimicrobial properties, making the product suitable for managing bacterial, fungal, and viral skin conditions, including those in sensitive anal and genital areas. It is marketed in Germany as a traditional herbal medicine and is available in pharmacies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Chamo Bürger Kamillenpuder.